|
|
||||||||
Papers In Press, published online ahead of print January 1, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Medicine, McGill University Health Centre, Montreal, Quebec H3A 1A1
Corresponding Author: Katherine.Cianflone{at}mcgill.ca
Acylation stimulating protein (ASP) increases triglyceride (TG) storage (fatty acid trapping) in adipose tissue and plays an important role in postprandial TG clearance. We examined the capacity of ASP and insulin to stimulate the activity of lipoprotein lipase (LPL) and the trapping of LPL-derived non-esterified fatty acid (NEFA) in 3T3-L1 adipocytes. While insulin increased total LPL activity (secreted and cell-associated, p<0.001) in 3T3-L1 adipocytes, ASP moderately stimulated secreted LPL activity (p=0.04, 5% of total LPL activity). Neither hormone increased LPL translocation from adipocytes to endothelial cells in a co-culture system. However, both ASP and insulin increased Vmax of in situ LPL activity (3H-TG synthetic lipoprotein hydrolysis and 3H-NEFA incorporation into adipocytes) by 60% and 41% respectively (p<0.01) without affecting KM. Tetrahydrolipstatin (LPL inhibitor) diminished baseline, ASP and insulin-stimulated in situ LPL activity resulting in 3H-TG accumulation (p<0.0001). Unbound oleate inhibited in situ LPL activity (p<0.0001) but did not eliminate ASP stimulatory effect. Therefore 1) the clearance of TG-rich lipoproteins is enhanced by ASP through increasing TG storage and relieving NEFA inhibition of LPL, and 2) the effectiveness of adipose tissue trapping of LPL-derived NEFA determines overall LPL activity, which in turn, determines the efficiency of postprandial TG clearance.
Revised on December 22, 2003
Accepted on December 26, 2003
ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Roy, S. Paglialunga, A. Fisette, P. Schrauwen, E. Moonen-Kornips, J. St-Onge, M. K. Hesselink, D. Richard, D. R. Joanisse, and K. Cianflone Shift in metabolic fuel in acylation-stimulating protein-deficient mice following a high-fat diet Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1051 - E1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Paglialunga, A. Fisette, Y. Yan, Y. Deshaies, J.-F. Brouillette, M. Pekna, and K. Cianflone Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E521 - E529. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cui, S. Paglialunga, D. Kalant, H. Lu, C. Roy, M. Laplante, Y. Deshaies, and K. Cianflone Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1482 - E1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Laplante, W. T. Festuccia, G. Soucy, Y. Gelinas, J. Lalonde, and Y. Deshaies Involvement of adipose tissues in the early hypolipidemic action of PPAR{gamma} agonism in the rat Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1408 - R1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Laplante, W. T. Festuccia, G. Soucy, Y. Gelinas, J. Lalonde, J. P. Berger, and Y. Deshaies Mechanisms of the Depot Specificity of Peroxisome Proliferator-Activated Receptor {gamma} Action on Adipose Tissue Metabolism. Diabetes, October 1, 2006; 55(10): 2771 - 2778. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marcil, H. Vu, W. Cui, Z. Dastani, J. C. Engert, D. Gaudet, M. Castro-Cabezas, A. D. Sniderman, J. Genest Jr, and K. Cianflone Identification of a Novel C5L2 Variant (S323I) in a French Canadian Family With Familial Combined Hyperlipemia Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1619 - 1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Faraj and K. Cianflone Differential regulation of fatty acid trapping in mouse adipose tissue and muscle by ASP Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E150 - E159. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |